PP
LGND icon

Paloma Partners’s Ligand Pharmaceuticals LGND Stock Holding History

Paloma Partners’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-16,844
Closed -$1.18M – 2287
2020
Q2 		$1.18M Buy
+16,844
New +$1.07M 0.02% 850
2020
Q1 		– Sell
-9,118
Closed -$593K – 1695
2019
Q4 		$593K Sell
9,118
-849
-9% -$56.7K 0.01% 1289
2019
Q3 		$619K Sell
9,967
-22,543
-69% -$1.42M 0.01% 1008
2019
Q2 		$2.31M Buy
+32,510
New +$2.39M 0.04% 369
2018
Q4 		– Sell
-3,280
Closed -$562K – 1551
2018
Q3 		$562K Buy
+3,280
New +$495K 0.01% 976
2017
Q4 		– Sell
-3,527
Closed -$300K – 2131
2017
Q3 		$300K Buy
+3,527
New +$279K ﹤0.01% 1799
2017
Q1 		– Sell
-4,660
Closed -$295K – 2115
2016
Q4 		$295K Buy
+4,660
New +$294K ﹤0.01% 1704
2016
Q2 		– Sell
-3,073
Closed -$206K – 2245
2016
Q1 		$206K Sell
3,073
-614
-17% -$37.3K ﹤0.01% 1680
2015
Q4 		$249K Buy
+3,687
New +$228K 0.01% 1436
2015
Q1 		– Sell
-16,609
Closed -$551K – 1318
2014
Q4 		$551K Buy
+16,609
New +$540K 0.02% 632
2014
Q2 		– Sell
-56,105
Closed -$2.35M – 1169
2014
Q1 		$2.35M Sell
56,105
-28,854
-34% -$1.2M 0.15% 134
2013
Q4 		$2.79M Buy
84,959
+36,067
+74% +$1.18M 0.14% 154
2013
Q3 		$1.32M Buy
48,892
+8,817
+22% +$248K 0.05% 288
2013
Q2 		$936K Buy
+40,075
New +$721K 0.05% 275

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return

Paloma Partners's LGND Position: Q3 2020 in Review

Paloma Partners sold out of Ligand Pharmaceuticals (LGND) in Q3 2020, closing a stake of 16,844 shares — an estimated $1.18M sold.

Paloma Partners first reported a position in LGND in Q2 2013 and held it in 14 quarters. The position peaked at $2.79M in Q4 2013. 252 funds tracked by Wall St. Rank hold LGND as of Q3 2020.

  • Paloma Partners reported no remaining Ligand Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Paloma Partners sold 16,844 Ligand Pharmaceuticals shares in Q3 2020, an estimated $1.18M.
  • Paloma Partners first reported a position in Ligand Pharmaceuticals in Q2 2013 and held it in 14 quarters.
  • Paloma Partners's Ligand Pharmaceuticals position peaked at $2.79M in Q4 2013.
  • 252 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2020.

Based on Paloma Partners's 13F filing for Q3 2020, filed 16 Nov 2020.